Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...

Robert Redman has had many treatments for brain and spinal cord cancer in the past 17 years, including proton, gamma and ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

“As a Seattle native, I have always been aware of the amazing research and innovation at Fred Hutch. When my life was touched by cancer, I knew it was time to get more involved and support this ...

Save the Date: the Sloan Precision Oncology Institute is hosting a Theranostics Symposium on February 28, 2025. This symposium will feature a panel of local and national leaders in the field who will ...

Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...

Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as ...

The turn of the calendar year marks a natural time to check in, evaluate goals, measure success and reset for the coming year and former patients of Fred Hutch Cancer Center – Proton Therapy are no ...

As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...

Merkel cell carcinoma, or MCC, is so rare that newly diagnosed patients are often the first case their oncologist has ever treated. For many patients, understanding this aggressive skin cancer’s ...

Vaccines are arguably one of the most important medical innovations in human history. When it comes to which diseases have successfully been targeted with vaccines, however, the playing field is far ...

Blood and bone marrow transplantation (also known as hematopoietic cell transplantation, or HCT) was developed at Fred Hutch nearly 50 years ago to cure leukemias and other diseases of the immune ...